Does hypertriglyceridemia present an indication for pioglitazone therapy in diabetes?
Kane
John P
JP
Cardiovascular Research Institute, University of California-San Francisco, 505 Parnassus Avenue, L-1337, Box 0130, San Francisco, CA 94143-0130, USA. kane@itsa.ucsf.edu
D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D015228:Hypertriglyceridemia / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance; D000077205:Pioglitazone; D013844:Thiazoles / Q000627:therapeutic use*; D045162:Thiazolidinediones
D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; C089946:2,4-thiazolidinedione; D000077205:Pioglitazone